18.01.2013 • NewsRocheRoche TamifluUSA

Roche Says US Allows it to Tap Adult Tamiflu Reserves

Roche Holding said U.S. regulators will allow it to begin selling the company's reserve stock of adult Tamiflu capsules, and that the extra supplies of the flu treatment should meet U.S. demand for that formulation for the rest of this flu season.

The Swiss drugmaker said the U.S. Food and Drug Administration will allow it to sell Tamiflu capsules in different packaging from what is currently available in the United States.

"The medicine from our reserve stock is the same as the medicine that is currently being distributed," and in the same 75 milligram adult dose, said company spokeswoman Tara Iannuccillo.

But Roche's Genentech unit, which makes Tamiflu, said it continues to expect spot shortages of a different liquid formulation used by children because continuing production of it will not meet demand.

The company said pharmacists can create a substitute liquid formulation by dissolving Tamiflu capsules into a sweet liquid.

Tamiflu is used to slow down or stop symptoms of the flu in people that already have been infected with the virus.

Shortages of the treatment come as the United States is experiencing one of the worst influenza epidemics of the past decade.

Health officials have said it is not too late for people to be vaccinated, but many across the country have had difficulty finding available vaccines at doctors' offices and drugstores.

Sanofi, the largest flu vaccine provider in the United States, last week said it had sold out of four of the six formulations of its Fluzone seasonal flu vaccine due to the unanticipated late-season demand for vaccines.

Drugstore chain Rite Aid Corp on Thursday said it had obtained more than 400,000 additional doses of seasonal flu shots, which are being delivered to areas of need based on actual or anticipated flu outbreak. The vaccine will be administered by pharmacists in its U.S. drugstores.

Safeway on Wednesday said it had shipped an additional 200,000 does of its vaccine to its U.S. pharmacies to meet high demand. The supermarket chain offered customers who receive the vaccine a coupon for 10% off their next grocery purchase.

Forty-seven states are reporting widespread influenza activity, and the nation's capital is also battling the seasonal scourge, which can be spread to others up to six feet away when people with flu cough, sneeze or talk.

Dozens of hand sanitizers cropped up this week at the U.S. Capitol in Washington, amidst heated preparations, and intense security, for President Barack Obama's second inauguration on Monday.

With hundreds of thousands of people expected to jam the city - particularly at crowded inaugural balls - health officials warned those who attend to wash their hands regularly and consider bringing hand sanitizer. And they had advice both for those who are ill - Stay home - and for those who are not: Get vaccinated, if you have not already done so.

 

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

most read

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
24.01.2025 • News

CEFIC Publishes 2024 Facts and Figures Report

CEFIC , the European Chemical Industry Council, has published its 2024 Facts & Figures report, which reinforces the need to take bold and urgent action to secure Europe’s industrial future, not only to implement the Green Deal but also to prevent further de-industrialization in Europe.

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.